HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of human challenge and MDR strains of Neisseria gonorrhoeae with LpxC inhibitors.

AbstractObjectives:
Inhibitors of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), which catalyses the second step in the biosynthesis of lipid A, have been developed as potential antibiotics for Gram-negative infections. Our objectives were to determine the effect of LpxC inhibition on the in vitro survival and inflammatory potential of Neisseria gonorrhoeae.
Methods:
Survival of four human challenge strains was determined after treatment with two LpxC inhibitors for 2 and 4 h. To confirm results from treatment and assess their anti-inflammatory effect, the expression of TNF-α by human THP-1 monocytic cells infected with bacteria in the presence of the LpxC inhibitors was quantified. Cytotoxicity of inhibitors for THP-1 cells was evaluated by release of lactate dehydrogenase. Survival of five MDR strains was determined after 2 h of treatment with an LpxC inhibitor and the effect of co-treatment on MICs of ceftriaxone and azithromycin was examined.
Results:
The inhibitors had bactericidal activity against the four human challenge and five MDR strains with one compound exhibiting complete killing at ≥5 mg/L after either 2 or 4 h of treatment. Treatment of gonococci infecting THP-1 monocytic cells reduced the levels of TNF-α probably owing to reduced numbers of bacteria and a lower level of expression of lipooligosaccharide. Neither inhibitor exhibited cytotoxicity for THP-1 cells. The MIC of azithromycin was slightly lowered by sublethal treatment of two MDR strains with an LpxC inhibitor.
Conclusions:
Our in vitro results demonstrated promising efficacy of LpxC inhibition of N. gonorrhoeae that warrants further investigation particularly owing to the rise in MDR gonorrhoea.
AuthorsConstance M John, Dongxiao Feng, Gary A Jarvis
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 73 Issue 8 Pg. 2064-2071 (08 01 2018) ISSN: 1460-2091 [Electronic] England
PMID29726994 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Tumor Necrosis Factor-alpha
  • Amidohydrolases
  • N-acetylglucosamine deacetylase
Topics
  • Amidohydrolases (antagonists & inhibitors)
  • Anti-Bacterial Agents (pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Monocytes (cytology, microbiology)
  • Neisseria gonorrhoeae (drug effects, enzymology)
  • THP-1 Cells
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: